Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$152.8K
7.41K shares
What this filing means
METZGER MICHAEL A plans to sell 7.41K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $152.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/6/2026ACC: 0001959173-26-000725
Officer· President and COO
Since Feb 2019
7.41K
Shares to sell
$152.8K
Approx. market value
7.41K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/5/2026
7.41KTotal acquired7.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/5/2026 | Restricted Stock Vesting Compensation | 7.41K | — |
| Total | 7.41K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.41K
Market value
$152.8K
2/6/2026
Total
Units
7.41K
Value
$152.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/6/2026 | 7.41K | $152.8K | NASDAQ | Planned |
| Total | 7.41K | $152.8K | ||